Reproductive factors and epithelial ovarian cancer survival in the EPIC cohort study

British Journal of Cancer

Volumn 113, Issue 11, 2015, Pages 1622-1631

  Be͉ević, Jelena ^a   Gunter, Marc J ^a   Fortner, Renee T ^b   Tsilidis, Konstantinos K ^a,c   Weiderpass, Elisabete ^d,e,f,g   Onland Moret, N Charlotte ^h   Dossus, Laure ^i,j,k   TjØnneland, Anne ^l   Hansen, Louise ^l   Overvad, Kim ^m   Mesrine, Sylvie ^i,j,k   Baglietto, Laura ^n,o   Clavel Chapelon, Francoise ^i,j,k   Kaaks, Rudolf ^b   Aleksandrova, Krasimira ^p   Boeing, Heiner ^p   Trichopoulou, Antonia ^q,r   Lagiou, Pagona ^s,t   Bamia, Christina ^t   Masala, Giovanna ^u   Agnoli, Claudia ^v   Tumino, Rosario ^w   Ricceri, Fulvio ^x,y   Panico, Salvatore ^z   Bueno de Mesquita, H B ^a,h,aa,ab   Peeters, Petra H ^a,h   Jareid, Mie ^d   Quirós, J Ramon ^ac   Duell, Eric J ^ad   Sánchez, Maria Jose ^ae,af   Larrañaga, Nerea ^af,ag   Chirlaque, Maria Dolores ^af,ah   Barricarte, Aurelio ^af,ai,aj   Dias, Joana A ^ak   Sonestedt, Emily ^ak   Idahl, Annika ^al   Lundin, Eva ^al   Wareham, Nicholas J ^am   Khaw, Kay Tee ^an   Travis, Ruth C ^ao   Rinaldi, Sabina ^ap   Romieu, Isabelle ^ap   Riboli, Elio ^a   Merritt, Melissa A ^a   more..

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF IOANNINA   (Greece)

^d UNIVERSITY OF TROMSØ   (Norway)

^e Cancer Registry of Norway ^*  (Norway)

^f KAROLINSKA INSTITUTE   (Sweden)

^g FOLKHÄLSAN RESEARCH CENTER   (Finland)

^h UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

ⁱ CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^j UNIVERSITÉ PARIS SACLAY   (France)

^k INSTITUT GUSTAVE ROUSSY   (France)

^l DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^m AARHUS UNIVERSITY   (Denmark)

ⁿ CANCER EPIDEMIOLOGY CENTRE   (Australia)

^o UNIVERSITY OF MELBOURNE   (Australia)

^p GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^q HELLENIC HEALTH FOUNDATION   (Greece)

^r BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^s HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^t UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^u CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^v NATIONAL CANCER INSTITUTE   (Italy)

^w CIVILE M P AREZZO HOSPITAL   (Italy)

^x ASL TO3 Piedmont Region   (Italy)

^y UNIVERSITY OF TURIN   (Italy)

^z UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^aa NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^ab UNIVERSITY OF MALAYA   (Malaysia)

^ac Hospital de Asturias   (Spain)

^ad CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^ae ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^af CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^ag Basque Government   (Spain)

^ah DEPARTMENT OF EPIDEMIOLOGY   (Spain)

^ai INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^aj IdiSNA Navarra Institute for Health Research   (Spain)

^ak LUND UNIVERSITY   (Sweden)

^al UMEÅ UNIVERSITY   (Sweden)

^am UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^an UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^ao UNIVERSITY OF OXFORD   (United Kingdom)

^ap INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

more..

Author keywords

epithelial ovarian cancer; menopausal hormone therapy; oral contraceptives; parity; survival

Indexed keywords

ADULT; ARTICLE; BODY MASS; CANCER HORMONE THERAPY; CANCER SURVIVAL; COHORT ANALYSIS; FAMILY HISTORY; FEMALE; FOLLOW UP; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; MENARCHE; MENOPAUSE; MORTALITY; ORAL CONTRACEPTIVE USE; OUTCOME ASSESSMENT; OVARIECTOMY; OVARY CARCINOMA; PARITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUESTIONNAIRE; REPRODUCTIVE HISTORY; SMOKING; AGE; AGED; BREAST FEEDING; EPIDEMIOLOGY; ESTROGEN THERAPY; EUROPE; MIDDLE AGED; NEOPLASM; OVARY TUMOR; PATHOLOGY; SURVIVAL RATE; VERY ELDERLY;

ORAL CONTRACEPTIVE AGENT;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST FEEDING; CONTRACEPTIVES, ORAL; ESTROGEN REPLACEMENT THERAPY; EUROPE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MENARCHE; MENOPAUSE; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PARITY; SURVIVAL RATE;

EID: 84949318864     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2015.377     Document Type: Article

References (31)

1. Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, Bannon F, Ahn JV, Johnson CJ, Bonaventure A, Marcos-Gragera R, Stiller C, Silva Azevedo E, Chen WQ, Ogunbiyi OJ, Rachet B, Soeberg MJ, You H, Matsuda T, Bielska-Lasota M, Storm H, Tucker TC, Coleman MP. (2014). Global surveillance of cancer survival 1995-2009: analysis of individual data for 25 676 887 patients from 279 populationbased registries in 67 countries (CONCORD-2). Lancet 385(9972): 977-1010.
2. Beral V, Doll R, Hermon C, Peto R, Reeves G. (2008). Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23, 257 women with ovarian cancer and 87, 303 controls. Lancet 371(9609): 303-314.
3. Beral V, Gaitskell K, Hermon C, Moser K, Reeves G, Peto R. (2015). Menopausal hormone use and ovarian cancer risk: individual participant meta-Analysis of 52 epidemiological studies. Lancet 385(9980): 1835-1842.
4. Cramer DW, Welch WR. (1983). Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. J Natl Cancer Inst 71(4): 717-721.
5. Cunat S, Hoffmann P, Pujol P. (2004). Estrogens and epithelial ovarian cancer. Gynecol Oncol 94(1): 25-32.
6. Fortner RT, Ose J, Merritt MA, Schock H, Tjonneland A, Hansen L, Overvad K, Dossus L, Clavel-Chapelon F, Baglietto L, Boeing H, Trichopoulou A, Benetou V, Lagiou P, Agnoli C, Mattiello A, Masala G, Tumino R, Sacerdote C, Bueno-de-Mesquita HB, Onland-Moret NC, Peeters PH, Weiderpass E, Torhild GI, Duell EJ, Larranaga N, Ardanaz E, Sanchez MJ, Chirlaque MD, Brandstedt J, Idahl A, Lundin E, Khaw KT, Wareham N, Travis RC, Rinaldi S, Romieu I, Gunter MJ, Riboli E, Kaaks R. (2015). Reproductive and hormone-related risk factors for epithelial ovarian cancer by histologic pathways, invasiveness and histologic subtypes: results from the EPIC cohort. Int J Cancer 137: 1196-1208.
7. Grambsch P, Therneau T. (1994). Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81: 515-526.
8. Greenland S. (1989). Modeling and variable selection in epidemiologic analysis. Am J Public Health 79(3): 340-349.
9. Jacobsen BK, Vollset SE, Kvale G. (1993). Reproductive factors and survival from ovarian cancer. Int J Cancer 54(6): 904-906.
10. Jarboe EA, Folkins AK, Drapkin R, Ince TA, Agoston ES, Crum CP. (2008). Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective. Histopathology 53(2): 127-138.
11. Kjaerbye-Dhygesen A, Frederiksen K, Hogdall EV, Hogdall CK, Blaakaer J, Kjaer SK. (2006). Do risk factors for epithelial ovarian cancer have an impact on prognosis? Focus on previous pelvic surgery and reproductive variables. Eur J Gynaecol Oncol 27(5): 467-472.
12. Kurman RJ, Shih I. (2011). Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer-shifting the paradigm. Hum Pathol 42(7): 918-931.
13. Lahmann PH, Hoffmann K, Allen N, van Gils CH, Khaw KT, Tehard B, Berrino F, Tjonneland A, Bigaard J, Olsen A, Overvad K, Clavel-Chapelon F, Nagel G, Boeing H, Trichopoulos D, Economou G, Bellos G, Palli D, Tumino R, Panico S, Sacerdote C, Krogh V, Peeters PH, Bueno-de-Mesquita HB, Lund E, Ardanaz E, Amiano P, Pera G, Quiros JR, Martinez C, Tormo MJ, Wirfalt E, Berglund G, Hallmans G, Key TJ, Reeves G, Bingham S, Norat T, Biessy C, Kaaks R, Riboli E. (2004). Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC). Int J Cancer 111(5): 762-771.
14. Mascarenhas C, Lambe M, Bellocco R, Bergfeldt K, Riman T, Persson I, Weiderpass E. (2006). Use of hormone replacement therapy before and after ovarian cancer diagnosis and ovarian cancer survival. Int J Cancer 119(12): 2907-2915.
15. Modesitt SC, van Nagell Jr. JR. (2005). The impact of obesity on the incidence and treatment of gynecologic cancers: a review. Obstet Gynecol Surv 60(10): 683-692.
16. Modugno F, Laskey RA, Smith AL, Andersen CL, Haluska P, Oesterreich S. (2012). Hormone response in ovarian cancer: time to reconsider as a clinical target? Endocr Relat Cancer 19(6): R255-R279.
17. Nagle CM, Bain CJ, Green AC, Webb PM. (2008). The influence of reproductive and hormonal factors on ovarian cancer survival. Int J Gynecol Cancer 18(3): 407-413.
18. Prat J. (2014). Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet 124(1): 1-5.
19. R Core Team. (2014). R: A language and environment for statistical computing. R Foundation for Statistical Computing: Vienna, Austria. Available at http://www.R-project.org/ (accessed 12 September 2014
20. Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, Charrondiere UR, Hemon B, Casagrande C, Vignat J, Overvad K, Tjonneland A, Clavel-Chapelon F, Thiebaut A, Wahrendorf J, Boeing H, Trichopoulos D, Trichopoulou A, Vineis P, Palli D, Bueno-de-Mesquita HB, Peeters PH, Lund E, Engeset D, Gonzalez CA, Barricarte A, Berglund G, Hallmans G, Day NE, Key TJ, Kaaks R, Saracci R. (2002). European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 5(6B): 1113-1124.
21. Riman T, Nilsson S, Persson IR. (2004). Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies. Acta Obstet Gynecol Scand 83(9): 783-795.
22. Risch HA. (1998). Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst 90(23): 1774-1786.
23. Robbins CL, Whiteman MK, Hillis SD, Curtis KM, McDonald JA, Wingo PA, Kulkarni A, Marchbanks PA. (2009). Influence of reproductive factors on mortality after epithelial ovarian cancer diagnosis. Cancer Epidemiol Biomarkers Prev 18(7): 2035-2041.
24. Rosen DG, Yang G, Liu G, Mercado-Uribe I, Chang B, Xiao XS, Zheng J, Xue FX, Liu J. (2009). Ovarian cancer: pathology, biology, and disease models. Front Biosci (Landmark Ed) 14: 2089-2102.
25. Tew WP, Muss HB, Kimmick GG, von Gruenigen VE, Lichtman SM. (2014). Breast and ovarian cancer in the older woman. J Clin Oncol 32(24): 2553-2561.
26. Therneau T. (2014). A Package for Survival Analysis in S. R package version 2.37-7.
27. Tsilidis KK, Allen NE, Key TJ, Dossus L, Lukanova A, Bakken K, Lund E, Fournier A, Overvad K, Hansen L, Tjonneland A, Fedirko V, Rinaldi S, Romieu I, Clavel-Chapelon F, Engel P, Kaaks R, Schutze M, Steffen A, Bamia C, Trichopoulou A, Zylis D, Masala G, Pala V, Galasso R, Tumino R, Sacerdote C, Bueno-de-Mesquita HB, van Duijnhoven FJ, Braem MG, Onland-Moret NC, Gram IT, Rodriguez L, Travier N, Sanchez MJ, Huerta JM, Ardanaz E, Larranaga N, Jirstrom K, Manjer J, Idahl A, Ohlson N, Khaw KT, Wareham N, Mouw T, Norat T, Riboli E. (2011). Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition. Br J Cancer 105(9): 1436-1442.
28. Wernli KJ, Newcomb PA, Hampton JM, Trentham-Dietz A, Egan KM. (2008). Hormone therapy and ovarian cancer: incidence and survival. Cancer Causes Control 19(6): 605-613.
29. Whittemore AS, Harris R, Itnyre J. (1992). Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol 136(10): 1184-1203.
30. Yang L, Klint A, Lambe M, Bellocco R, Riman T, Bergfeldt K, Persson I, Weiderpass E. (2008). Predictors of ovarian cancer survival: a population-based prospective study in Sweden. Int J Cancer 123(3): 672-679.
31. Zhang M, Holman CD. (2012). Tubal ligation and survival of ovarian cancer patients. J Obstet Gynaecol Res 38(1): 40-47.